Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-6.68%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-6.68%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
-67.59%
20%
—
—
Never
—
5 Years
Score—
Net Growth-67.59%
Net Trend20%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
CNS Pharmaceuticals Inc fundamental performance
Across CNS Pharmaceuticals Inc's full reported history, from 2019 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 3M to -$ 15M. Revenue increased in 0% of the years measured; net income in 17%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 5.01 | — |
1 Year2025-08-12 | $ 6.57 | -23.74% |
5 Years2021-08-12 | $ 1000K | -100.00% |
All Time2019-11-08 | $ 1000K | -100.00% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2019-11-08 |
|---|---|---|---|---|
| Price | $ 5.01 | $ 6.57 | $ 1000K | $ 1000K |
| Return | — | -23.74% | -100.00% | -100.00% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 0.00 | -$ 15M | $ 7M |
| 2024 | $ 0.00 | -$ 14M | $ 6M |
| 2023 | $ 0.00 | -$ 18M | $ 548.72K |
| 2022 | $ 0.00 | -$ 15M | $ 10M |
| 2021 | $ 0.00 | -$ 14M | $ 5M |
| 2020 | $ 0.00 | -$ 9M | $ 14M |
| IPO2019 | $ 0.00 | -$ 3M | $ 7M |
Explore beyond CNSP
You're looking at CNS Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
